选择性抑制蛋白激酶D2活动 降低人类中性粒细胞的生存率
1Global Drug Safety Research Evaluation, Takeda Pharmaceutical Company Ltd., Pharmaceutical Research Division, Cambridge, MA, U.S.A. nori.uchi.koku3@gmail.com.
Anticancer research
|January 30, 2026
概括
蛋白激酶D2 (PKD2) 对于人类中性粒细胞的生存至关重要. 用小分子抑制PKD2降低了中性粒细胞的活力,这表明了减轻癌症患者中性粒细胞衰竭的策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 小分子抗癌药物可能会导致中性质减退,这是一个常见的不良反应,其特点是白细胞数量低.
- 蛋白激酶D2 (PKD2) 在中性粒细胞中高度表达,使其成为理解和减轻药物诱导的中性粒症的潜在目标.
研究的目的:
- 调查蛋白激酶D2 (PKD2) 在人类中性粒细胞存活中的作用.
- 评估针对PKD2的小分子抑制剂对中性粒细胞活力的影响.
- 评估PKD2抑制与体内白细胞计数之间的相关性.
主要方法:
- 对PLK1抑制剂 (TAK-960衍生物,化合物A) 对265种激酶酶的评估激酶抑制特征.
- 利用siRNA在分化的HL60细胞中敲除PKD2,并评估细胞活力.
- 测试了小分子化合物对分化HL60细胞和人类初级中性粒细胞的影响.
- 在小鼠异种移植模型中评估了PKD2抑制和外周白细胞计数之间的相关性.
主要成果:
- 抗击PKD2显著降低了分化HL60细胞的活力.
- 化合物A是一种选择性PKD2抑制剂,在分化HL60细胞和人类中性粒细胞中显著降低了活力.
- 在小鼠中,PKD2抑制与白细胞计数增加有显著的正相关性 (r=0.75,p=0.009).
结论:
- 蛋白激酶D2 (PKD2) 在维持人类中性粒细胞生存方面发挥着至关重要的作用.
- 针对小分子抗癌药物设计中的PKD2抑制可能是降低患者中性衰竭风险的关键.
相关概念视频
Protein Kinases and Phosphatases
15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases
4.5K
4.5K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
cAMP-dependent Protein Kinase Pathways
8.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
T Cell Activation and Clonal Selection
16.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.0K


